Ghost Tree Capital as of Sept. 30, 2017
Portfolio Holdings for Ghost Tree Capital
Ghost Tree Capital holds 55 positions in its portfolio as reported in the September 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Zogenix | 9.3 | $44M | 1.3M | 35.05 | |
| Dbv Technologies S A (DBVT) | 7.4 | $35M | 824k | 42.44 | |
| SPDR S&P Biotech (XBI) | 6.4 | $30M | 350k | 86.57 | |
| Avexis | 6.3 | $30M | 305k | 96.73 | |
| Immunomedics | 5.8 | $27M | 1.9M | 13.98 | |
| Insmed (INSM) | 4.1 | $20M | 624k | 31.21 | |
| Bristol Myers Squibb (BMY) | 3.0 | $14M | 225k | 63.75 | |
| Alexion Pharmaceuticals | 3.0 | $14M | 100k | 140.29 | |
| Neurocrine Biosciences (NBIX) | 2.9 | $14M | 225k | 61.28 | |
| Acceleron Pharma | 2.8 | $13M | 350k | 37.32 | |
| Nevro (NVRO) | 2.2 | $11M | 115k | 90.88 | |
| Entellus Medical Cm | 2.2 | $10M | 562k | 18.46 | |
| Thermo Fisher Scientific (TMO) | 2.0 | $9.5M | 50k | 189.20 | |
| Sage Therapeutics (SAGE) | 2.0 | $9.3M | 150k | 62.30 | |
| GenMark Diagnostics | 1.9 | $9.1M | 950k | 9.63 | |
| Zimmer Holdings (ZBH) | 1.9 | $8.8M | 75k | 117.09 | |
| Aimmune Therapeutics | 1.8 | $8.7M | 350k | 24.79 | |
| Boston Scientific Corporation (BSX) | 1.7 | $8.0M | 275k | 29.17 | |
| Intercept Pharmaceuticals In | 1.7 | $7.8M | 135k | 58.03 | |
| Puma Biotechnology (PBYI) | 1.6 | $7.8M | 65k | 119.75 | |
| Global Blood Therapeutics In | 1.6 | $7.8M | 250k | 31.05 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 1.6 | $7.6M | 50k | 152.04 | |
| Ascendis Pharma A S (ASND) | 1.5 | $7.3M | 200k | 36.25 | |
| Spark Therapeutics | 1.5 | $7.1M | 80k | 89.16 | |
| Irhythm Technologies (IRTC) | 1.5 | $7.0M | 135k | 51.88 | |
| Ignyta | 1.4 | $6.8M | 550k | 12.35 | |
| Patterson Companies (PDCO) | 1.3 | $6.2M | 160k | 38.65 | |
| Aquinox Pharmaceuticals | 1.2 | $5.7M | 400k | 14.19 | |
| Argenx Se (ARGX) | 1.2 | $5.7M | 253k | 22.61 | |
| Nanostring Technologies (NSTGQ) | 1.2 | $5.6M | 345k | 16.16 | |
| Gw Pharmaceuticals Plc ads | 1.1 | $5.1M | 50k | 101.50 | |
| Sarepta Therapeutics (SRPT) | 1.0 | $4.5M | 100k | 45.36 | |
| Juno Therapeutics | 0.9 | $4.5M | 100k | 44.86 | |
| Merck & Co (MRK) | 0.9 | $4.2M | 65k | 64.03 | |
| Incyte Corporation (INCY) | 0.9 | $4.1M | 35k | 116.74 | |
| Alnylam Pharmaceuticals (ALNY) | 0.9 | $4.1M | 35k | 117.49 | |
| ACADIA Pharmaceuticals (ACAD) | 0.9 | $4.1M | 109k | 37.67 | |
| Viewray (VRAYQ) | 0.9 | $4.0M | 700k | 5.76 | |
| Ptc Therapeutics I (PTCT) | 0.8 | $4.0M | 200k | 20.01 | |
| CurrencyShares British Pound Ster. Trst | 0.8 | $3.9M | 30k | 130.33 | |
| Neos Therapeutics | 0.8 | $3.7M | 400k | 9.15 | |
| Aerie Pharmaceuticals | 0.8 | $3.6M | 75k | 48.60 | |
| Ra Pharmaceuticals | 0.7 | $3.4M | 235k | 14.60 | |
| Amicus Therapeutics (FOLD) | 0.6 | $3.0M | 200k | 15.08 | |
| Kadmon Hldgs | 0.6 | $2.8M | 850k | 3.35 | |
| Rigel Pharmaceuticals (RIGL) | 0.6 | $2.8M | 1.1M | 2.54 | |
| BioCryst Pharmaceuticals (BCRX) | 0.6 | $2.6M | 500k | 5.24 | |
| IRIDEX Corporation (IRIX) | 0.4 | $1.9M | 200k | 9.37 | |
| NuVasive | 0.3 | $1.7M | 30k | 55.47 | |
| Exelixis (EXEL) | 0.3 | $1.3M | 54k | 24.22 | |
| Deciphera Pharmaceuticals (DCPH) | 0.3 | $1.2M | 64k | 18.99 | |
| Nabriva Therapeutics | 0.2 | $983k | 120k | 8.19 | |
| Quotient | 0.2 | $924k | 188k | 4.93 | |
| Axovant Sciences | 0.1 | $688k | 100k | 6.88 | |
| Versartis | 0.1 | $674k | 275k | 2.45 |
